HK1211857A1 - 奧氮平半抗原的抗體及其用途 - Google Patents
奧氮平半抗原的抗體及其用途Info
- Publication number
- HK1211857A1 HK1211857A1 HK15112820.4A HK15112820A HK1211857A1 HK 1211857 A1 HK1211857 A1 HK 1211857A1 HK 15112820 A HK15112820 A HK 15112820A HK 1211857 A1 HK1211857 A1 HK 1211857A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibodies
- olanzapine haptens
- olanzapine
- haptens
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Anesthesiology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261691572P | 2012-08-21 | 2012-08-21 | |
PCT/US2013/055817 WO2014031656A1 (en) | 2012-08-21 | 2013-08-20 | Antibodies to olanzapine haptens and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211857A1 true HK1211857A1 (zh) | 2016-06-03 |
Family
ID=50148310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112820.4A HK1211857A1 (zh) | 2012-08-21 | 2015-12-30 | 奧氮平半抗原的抗體及其用途 |
Country Status (12)
Country | Link |
---|---|
US (3) | US20140057303A1 (zh) |
EP (2) | EP2887952B1 (zh) |
JP (2) | JP6389177B2 (zh) |
CN (2) | CN109400708A (zh) |
AU (3) | AU2013305895B2 (zh) |
CA (1) | CA2882595C (zh) |
ES (1) | ES2733963T3 (zh) |
HK (1) | HK1211857A1 (zh) |
PL (1) | PL2887952T3 (zh) |
PT (1) | PT2887952T (zh) |
TR (1) | TR201910347T4 (zh) |
WO (1) | WO2014031656A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108484496B (zh) | 2012-08-21 | 2022-03-22 | 詹森药业有限公司 | 阿立哌唑半抗原及其在免疫测定中的应用 |
US9465041B2 (en) | 2012-08-21 | 2016-10-11 | Janssen Pharmaceutica Nv | Antibodies to paliperidone and use thereof |
ES2666000T3 (es) | 2012-08-21 | 2018-04-30 | Janssen Pharmaceutica, N.V. | Anticuerpos para aripiprazol y uso de los mismos |
JP6374387B2 (ja) | 2012-08-21 | 2018-08-15 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンハプテンへの抗体及びその使用 |
TR201910347T4 (tr) | 2012-08-21 | 2019-07-22 | Janssen Pharmaceutica Nv | Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı. |
AU2013305907B2 (en) | 2012-08-21 | 2018-01-18 | Saladax Biomedical Inc. | Antibodies to quetiapine and use thereof |
TR201816416T4 (tr) | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
AU2013305904B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to quetiapine haptens and use thereof |
JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
JP6389176B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ.ベー. | アリピプラゾールハプテンに対する抗体及びその使用 |
CA2882596C (en) | 2012-08-21 | 2019-05-14 | Ortho-Clinical Diagnostics, Inc. | Antibodies to olanzapine and use thereof |
CN105601730A (zh) * | 2014-10-30 | 2016-05-25 | 北京维德维康生物技术有限公司 | 呋喃妥因半抗原和抗原的制备方法及其在化学发光免疫试剂盒中的应用 |
AU2016372069A1 (en) | 2015-12-17 | 2018-06-07 | Saladax Biomedical Inc. | Antibodies to risperidone and use thereof |
EP3390455A1 (en) | 2015-12-17 | 2018-10-24 | Janssen Pharmaceutica NV | Antibodies to quetiapine and use thereof |
CN110938082A (zh) * | 2019-10-30 | 2020-03-31 | 杭州博拓生物科技股份有限公司 | 一种奥氮平人工抗原及其制备方法 |
CN114685527B (zh) * | 2020-12-25 | 2024-03-05 | 长沙博源医疗科技有限公司 | 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用 |
CN115073492B (zh) * | 2022-08-22 | 2022-11-18 | 北京丹大生物技术有限公司 | 一种奥氮平衍生物抗原、奥氮平抗体及其应用 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228A (en) | 1849-03-27 | Coejsr-shelleb | ||
US4022780A (en) | 1973-03-06 | 1977-05-10 | Imperial Chemical Industries Limited | Process for the manufacture of indole derivatives |
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US6893625B1 (en) | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
ES2184734T3 (es) | 1987-04-27 | 2003-04-16 | Inverness Medical Switzerland | Dispositivo de prueba analitica para realizar ensayos de union especifica. |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
AU1331892A (en) * | 1991-02-01 | 1992-09-07 | Coulter Corporation | Method of producing f(ab')2 fragments of immunoglobulins |
DE69232002T2 (de) | 1991-06-07 | 2002-06-06 | Johnson & Johnson Clin Diag | Immunoassays unter Verwendung von markierten Hapten-Analogen |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
US5616505A (en) * | 1992-03-27 | 1997-04-01 | Abbott Laboratories | Haptens tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
US6034078A (en) | 1992-05-29 | 2000-03-07 | Eli Lilly And Company Limited | Thienobenzodiazepine compounds |
AU668159B2 (en) | 1992-05-29 | 1996-04-26 | Lilly Industries Limited | Pharmaceutical compounds |
US5527709A (en) | 1992-06-26 | 1996-06-18 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays with labeled thyronine hapten analogues |
US5642870A (en) | 1992-08-05 | 1997-07-01 | Sargis; Ike | Switch stand |
US5395933A (en) | 1992-08-07 | 1995-03-07 | Eastman Kodak Company | Carbamazepine hapten analogues |
CA2192467C (en) | 1994-06-10 | 2009-03-31 | Alireza Rezaie | Calcium binding recombinant antibody against protein c |
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5761894A (en) | 1996-09-25 | 1998-06-09 | Magic Circle Corporation | Grass striping attachment for lawn mowers |
US6139800A (en) | 1997-06-23 | 2000-10-31 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
US6830731B1 (en) | 1998-01-05 | 2004-12-14 | Biosite, Inc. | Immunoassay fluorometer |
US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
US20030143233A1 (en) | 1999-06-07 | 2003-07-31 | Neorx Corporation | Streptavidin expressed gene fusions and methods of use thereof |
UA76708C2 (uk) | 1999-12-08 | 2006-09-15 | Сінгента Патисипейшонс Аг | Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду |
US7163681B2 (en) * | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
US6958156B2 (en) | 2000-12-15 | 2005-10-25 | Vyrex Corporation | Isoflavone derivatives |
WO2003072736A2 (en) | 2002-02-21 | 2003-09-04 | Duke University | Reagents and treatment methods for autoimmune diseases |
EP1490090A4 (en) * | 2002-02-22 | 2006-09-20 | New River Pharmaceuticals Inc | SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS |
JP2005533009A (ja) | 2002-03-28 | 2005-11-04 | イーライ・リリー・アンド・カンパニー | ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用 |
SE0201738D0 (sv) | 2002-06-07 | 2002-06-07 | Aamic Ab | Micro-fluid structures |
WO2004011031A1 (en) | 2002-07-29 | 2004-02-05 | Potomac, Pharma, Llc. | Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic |
AU2003264915A1 (en) | 2002-08-05 | 2004-02-25 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines |
US20040193446A1 (en) * | 2003-03-27 | 2004-09-30 | Mayer Steven Lloyd | System and method for managing a patient treatment program including a prescribed drug regimen |
US7271252B2 (en) | 2003-04-22 | 2007-09-18 | Roche Diagnostics Operations, Inc. | Reagents for detecting efavirenz |
JP5416338B2 (ja) | 2003-05-09 | 2014-02-12 | デューク ユニバーシティ | Cd20特異的抗体およびその使用方法 |
MXPA06001938A (es) * | 2003-08-18 | 2006-05-17 | Lundbeck & Co As H | Trans-1-(6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina. |
CA2538745A1 (en) | 2003-09-23 | 2005-03-31 | Fermion Oy | Preparation of quetiapine |
CN100549004C (zh) | 2003-10-01 | 2009-10-14 | 阿得罗公司 | 螺环杂环衍生物及其应用方法 |
AU2004298660B2 (en) | 2003-12-12 | 2010-04-22 | Abbott Rapid Diagnostics International Unlimited Company | Assay |
SE0400662D0 (sv) | 2004-03-24 | 2004-03-24 | Aamic Ab | Assay device and method |
EP1748070A4 (en) | 2004-04-26 | 2007-07-18 | Takami Matsuyama | THERAPEUTIC WITH MONOCLONAL ANTIBODY AGAINST FOLAT RECEPTOR BETA (FR-BETA) |
SE527036C2 (sv) | 2004-06-02 | 2005-12-13 | Aamic Ab | Analysanordning med reglerat flöde och motsvarande förfarande |
TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
US20060235005A1 (en) | 2005-04-14 | 2006-10-19 | Oak Labs, Corp. | Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia |
SE529254C2 (sv) | 2005-06-17 | 2007-06-12 | Aamic Ab | Optiskt testsystem |
SE0501418L (sv) | 2005-06-20 | 2006-09-26 | Aamic Ab | Metod och medel för att åstadkomma vätsketransport |
SE529711C2 (sv) | 2006-03-22 | 2007-11-06 | Aamic Ab | Fluorescensläsare |
US8975374B2 (en) | 2006-10-20 | 2015-03-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
JP5450092B2 (ja) | 2006-12-29 | 2014-03-26 | アボット・ラボラトリーズ | 全血中の分子または薬物の検出のための診断検査 |
JP2010540920A (ja) | 2007-09-27 | 2010-12-24 | ノバルティス アーゲー | 薬物モニタリングアッセイ |
US8133743B2 (en) | 2007-10-19 | 2012-03-13 | Roche Diagnostics Operations, Inc. | Phenobarbital derivatives useful in immunoassay |
WO2010009987A2 (en) | 2008-07-21 | 2010-01-28 | Probiodrug Ag | Diagnostic antibody assay |
JP2011529923A (ja) * | 2008-08-06 | 2011-12-15 | ゴスフォース センター(ホールディングス)プロプライエタリー リミテッド | 精神障害(psychiatricdisorder)を治療するための組成物および方法 |
US20100069356A1 (en) | 2008-09-17 | 2010-03-18 | Auspex Pharmaceuticals, Inc. | Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors |
MX2011003598A (es) | 2008-10-14 | 2011-04-27 | Astrazeneca Ab | Compuestos heteroaromaticos espirociclicos, fusionados, para el tratamiento de infecciones bacterianas. |
EP2347015A4 (en) * | 2008-10-29 | 2012-12-19 | Janssen Pharmaceutica Nv | METHOD FOR THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE ERBB4 GEN |
EP2194048A1 (en) | 2008-12-02 | 2010-06-09 | Dirk Sartor | Nitrate esters for the treatment of vascular and metabolic diseases |
NZ594071A (en) * | 2009-01-26 | 2013-01-25 | Egalet Ltd | Controlled release formulations comprising morphine sulphate for continuous treatment of pain |
EP3138854B1 (en) | 2009-03-10 | 2022-01-26 | Baylor Research Institute | Antibodies against cd40 |
US8076097B2 (en) | 2009-08-19 | 2011-12-13 | Saladax Biomedical Inc. | Imatinib immunoassay |
RU2595843C2 (ru) * | 2009-10-16 | 2016-08-27 | Омик Аб | Способ анализа и устройства с применением магнитных частиц |
AU2010336981B2 (en) | 2009-12-31 | 2014-04-10 | Kempharm, Inc. | Amino acid conjugates of quetiapine, process for making and using the same |
EP2544536B1 (en) | 2010-03-11 | 2018-12-12 | Kempharm, Inc. | Fatty acid conjugates of quetiapine, process for making and using the same |
US8114621B2 (en) | 2010-03-12 | 2012-02-14 | Saladax Biomedical Inc. | Lenalidomide and thalidomide immunoassays |
US8088594B2 (en) | 2010-03-16 | 2012-01-03 | Saladax Biomedical Inc. | Risperidone immunoassay |
CN102260290A (zh) | 2010-05-25 | 2011-11-30 | 苏州波锐生物医药科技有限公司 | 喹喏啉酮类化合物及其在制备精神病药物中的用途 |
WO2011159537A2 (en) * | 2010-06-15 | 2011-12-22 | The Regents Of The University Of California | Method and device for analyte detection |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
US8623324B2 (en) | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
CN102276624B (zh) | 2011-06-17 | 2013-10-16 | 大连理工大学 | 一种奥氮平有关物质及其制备方法和高效液相色谱分析方法 |
CN102276592B (zh) | 2011-06-17 | 2013-10-16 | 大连理工大学 | 一种奥氮平有关物质及其制备方法、分析方法 |
AU2012351747B2 (en) | 2011-12-15 | 2016-05-12 | Alkermes Pharma Ireland Limited | Prodrugs of secondary amine compounds |
WO2014028800A1 (en) | 2012-08-16 | 2014-02-20 | Janssen Pharmaceutica Nv | Substituted pyrazoles as n-type calcium channel blockers |
AU2013305907B2 (en) | 2012-08-21 | 2018-01-18 | Saladax Biomedical Inc. | Antibodies to quetiapine and use thereof |
WO2014031587A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of olanzipine |
US9304126B2 (en) | 2012-08-21 | 2016-04-05 | Janssen Pharmaceutica Nv | Haptens of quetiapine |
CN108484496B (zh) | 2012-08-21 | 2022-03-22 | 詹森药业有限公司 | 阿立哌唑半抗原及其在免疫测定中的应用 |
CA2882596C (en) | 2012-08-21 | 2019-05-14 | Ortho-Clinical Diagnostics, Inc. | Antibodies to olanzapine and use thereof |
TR201816416T4 (tr) | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
JP6389176B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ.ベー. | アリピプラゾールハプテンに対する抗体及びその使用 |
JP6131500B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドン及びパリペリドンのハプテン |
ES2666000T3 (es) | 2012-08-21 | 2018-04-30 | Janssen Pharmaceutica, N.V. | Anticuerpos para aripiprazol y uso de los mismos |
TR201910347T4 (tr) | 2012-08-21 | 2019-07-22 | Janssen Pharmaceutica Nv | Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı. |
JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
US9465041B2 (en) | 2012-08-21 | 2016-10-11 | Janssen Pharmaceutica Nv | Antibodies to paliperidone and use thereof |
JP6374387B2 (ja) | 2012-08-21 | 2018-08-15 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンハプテンへの抗体及びその使用 |
WO2014031595A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of paliperidone |
AU2013305904B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to quetiapine haptens and use thereof |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
EP3390455A1 (en) | 2015-12-17 | 2018-10-24 | Janssen Pharmaceutica NV | Antibodies to quetiapine and use thereof |
AU2016372069A1 (en) | 2015-12-17 | 2018-06-07 | Saladax Biomedical Inc. | Antibodies to risperidone and use thereof |
EP3588013A1 (de) | 2018-06-26 | 2020-01-01 | XelectriX Power GmbH | Verfahren zur abgabe von elektrischer energie |
-
2013
- 2013-08-20 TR TR2019/10347T patent/TR201910347T4/tr unknown
- 2013-08-20 PL PL13830479T patent/PL2887952T3/pl unknown
- 2013-08-20 PT PT13830479T patent/PT2887952T/pt unknown
- 2013-08-20 CN CN201811255386.5A patent/CN109400708A/zh active Pending
- 2013-08-20 CA CA2882595A patent/CA2882595C/en active Active
- 2013-08-20 EP EP13830479.5A patent/EP2887952B1/en active Active
- 2013-08-20 ES ES13830479T patent/ES2733963T3/es active Active
- 2013-08-20 EP EP19174507.4A patent/EP3581195A1/en active Pending
- 2013-08-20 US US13/971,519 patent/US20140057303A1/en not_active Abandoned
- 2013-08-20 AU AU2013305895A patent/AU2013305895B2/en active Active
- 2013-08-20 JP JP2015528596A patent/JP6389177B2/ja active Active
- 2013-08-20 WO PCT/US2013/055817 patent/WO2014031656A1/en active Application Filing
- 2013-08-20 CN CN201380054990.0A patent/CN104755093B/zh active Active
-
2015
- 2015-12-30 HK HK15112820.4A patent/HK1211857A1/zh unknown
-
2017
- 2017-05-09 US US15/590,936 patent/US10712353B2/en active Active
- 2017-05-09 US US15/590,941 patent/US11226345B2/en active Active
-
2018
- 2018-01-19 AU AU2018200435A patent/AU2018200435B2/en active Active
- 2018-08-16 JP JP2018153217A patent/JP6721641B2/ja active Active
-
2019
- 2019-12-17 AU AU2019283807A patent/AU2019283807B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11226345B2 (en) | 2022-01-18 |
AU2019283807B2 (en) | 2021-04-29 |
AU2013305895B2 (en) | 2017-10-19 |
AU2018200435A1 (en) | 2018-02-08 |
PT2887952T (pt) | 2019-08-30 |
EP2887952A1 (en) | 2015-07-01 |
US20170240653A1 (en) | 2017-08-24 |
CN109400708A (zh) | 2019-03-01 |
EP2887952A4 (en) | 2016-04-13 |
JP2019004889A (ja) | 2019-01-17 |
ES2733963T3 (es) | 2019-12-03 |
JP2015529201A (ja) | 2015-10-05 |
WO2014031656A1 (en) | 2014-02-27 |
US20170343569A1 (en) | 2017-11-30 |
AU2018200435B2 (en) | 2019-09-19 |
EP2887952B1 (en) | 2019-05-15 |
TR201910347T4 (tr) | 2019-07-22 |
CN104755093A (zh) | 2015-07-01 |
JP6389177B2 (ja) | 2018-09-12 |
AU2019283807A1 (en) | 2020-01-16 |
US20140057303A1 (en) | 2014-02-27 |
CA2882595C (en) | 2019-06-04 |
JP6721641B2 (ja) | 2020-07-15 |
CA2882595A1 (en) | 2014-02-27 |
US10712353B2 (en) | 2020-07-14 |
PL2887952T3 (pl) | 2019-11-29 |
EP3581195A1 (en) | 2019-12-18 |
CN104755093B (zh) | 2018-11-16 |
AU2013305895A1 (en) | 2015-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211857A1 (zh) | 奧氮平半抗原的抗體及其用途 | |
HK1211957A1 (zh) | 利培酮半抗原的抗體及其用途 | |
HK1211959A1 (zh) | 喹硫平半抗原的抗體及其用途 | |
HK1255219A1 (zh) | 喹硫平的抗體及其用途 | |
HK1211955A1 (zh) | 阿立呱唑半抗原的抗體及其用途 | |
HK1212033A1 (zh) | 奧氮平的抗體及其用途 | |
HK1211956A1 (zh) | 帕潘立酮半抗原的抗體及其用途 | |
IL238559A0 (en) | Antibodies against ceacam5 and their use | |
HK1212034A1 (zh) | 利培酮的抗體及其用途 | |
HK1211958A1 (zh) | 帕潘立酮的抗體及其用途 | |
PT2888269T (pt) | Haptenos de olanzapina | |
IL238366A0 (en) | Antibodies to interleukin-6 and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AM | Amended specification (according sect 146 of patent law) |
Free format text: CORRECTION OF THE NAME OF THE APPLICANT FROM JANSSEN PHARMACEUTICA, N.V. T Effective date: 20190916 |